DCF — OLMSTED MEDICAL CENTER
Enterprise Value: $-455.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-455.2M
Enterprise Value
$-142.0M
PV of Cash Flows
$-313.3M
PV of Terminal Value
$-504.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $224.2M | $-29.5M | -13.0% | $-39.0M | $-35.4M |
| Year 2 | $230.9M | $-28.0M | -12.0% | $-37.8M | $-31.3M |
| Year 3 | $237.8M | $-26.5M | -11.0% | $-36.6M | $-27.5M |
| Year 4 | $245.0M | $-26.1M | -11.0% | $-36.5M | $-24.9M |
| Year 5 | $252.3M | $-26.2M | -10.0% | $-36.9M | $-22.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-455.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$217.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1364846997610201
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5